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ABSTRACT 38 
 39 
Background: Prenatal maternal stress may influence offspring’s atopic risk through 40 
sustained cortisol secretion resulting from activation of the hypothalamic-pituitary-axis (HPA), 41 
leading to Th2-biased cell differentiation in the fetus.  We undertook a systematic review and 42 
meta-analysis investigating the relationship between prenatal maternal psychosocial stress 43 
and risk of asthma and allergy in the offspring. 44 
Design:  45 
Methods: We searched 11 electronic databases from 1960 to 2016, search the grey 46 
literature, and contacted experts in the field. Type of stress indicator included mood 47 
disorders, anxiety, exposure to violence, bereavement and socio-economic problems 48 
occurring during pregnancy, both objectively or subjectively measured. We included all 49 
possible asthma and IgE-mediated allergy outcomes. We conducted random-effects meta-50 
analyses to synthesize the data. 51 
 52 
Results: We identified 9,779 papers of which 30 studies (enrolling >6 million participants) 53 
satisfied inclusion criteria. The quality of 25 studies was moderate, four were strong, and one 54 
was weak. Maternal exposure to any type of stressors was associated with an increased risk 55 
of offspring atopic eczema/dermatitis (OR 1.34, 95%CI 1.22-1.47), allergic rhinitis (OR 1.30, 56 
95%CI 1.04-1.62), wheeze (OR 1.34, 95%CI 1.16-1.54) and asthma (OR 1.15, 95%CI 1.04-57 
1.27). Exposure to anxiety and depression had strongest effect compared to other stressors. 58 
Exposure during the third trimester had the greatest impact compared to first and second 59 
trimesters. The increased risk was stronger for early-onset and persistent than for late-onset 60 
wheeze. Bereavement of a child (HR 1.28, 95%CI 1.10-1.48) or a spouse (HR 1.40, 95%CI 61 
1.03-1.90) increased the risk of offspring asthma. 62 
 63 
Conclusions: Exposure to prenatal maternal psychosocial stress was associated with 64 
increased risk, albeit modestly, of asthma and allergy in the offspring. The pronounced risk 65 
during the third trimester may represent cumulative stress exposure throughout pregnancy 66 
rather than trimester-specific effect. Our findings may represent a causal effect or a result of 67 
inherent biases in studies, particularly residual confounding. 68 
 69 
 70 
 71 
 72 
Systematic review registration: PROSPERO (2016:CRD42016036456) 73 
 74 
3 
 
 75 
INTRODUCTION 76 
The susceptibility to develop asthma and allergy may be established already in utero.1-4 The 77 
concept of fetal programming has provided important insights on the influence of the 78 
intrauterine environment on the development of the fetus and subsequent5 risk of chronic 79 
conditions later in life.6 As adaptive immunity develops prenatally, allergen specific immune 80 
responses are demonstrable in newborns2,3,7 with umbilical cord blood shown to contain 81 
fetally derived immunoglobulin E (IgE).1,3  82 
 83 
One suggested pathway through which prenatal maternal stress may influence the risk of 84 
asthma and allergy in the offspring is through the activation of the hypothalamic-pituitary-axis 85 
(HPA) in response to external stress.8,9 This then causes secretion of hormones by the 86 
hypothalamus and pituitary gland in the brain and subsequent stimulation of the release of 87 
glucocorticoids, adrenaline and noradrenaline.8-10 The release of glucocorticoids leads to 88 
increases in cortisol levels.8,9 The activities of the HPA and the resultant chemical reactions 89 
can be transmitted to the fetus and thus influences development.6,11 High levels of cortisol 90 
increase airway responsiveness in the offspring and potentiated cell differentiation from T 91 
helper cell type 1 (Th1) to T helper cell type 2 (Th2) phenotypes.12 Maternal stress can also 92 
lead to a decrease in the glutathione/glutathione disulfide (GSSG) ratio, leading to oxidative 93 
stress and subsequent risk of asthma in the offspring.8,9  94 
 95 
Several epidemiologic studies investigating indicators of prenatal maternal psychosocial 96 
stress on the risk of asthma and allergy in the offspring show that maternal exposure to 97 
stress may increase the risk of asthma and allergy in the offspring. Although two recent 98 
systematic reviews summarized existing studies,13,14 a comprehensive synthesis of the 99 
underlying evidence is lacking. In the first review, only wheeze and asthma outcomes were 100 
considered.13 Although the second review included the full spectrum of allergy outcomes, the 101 
searches were confined to a limited number of databases and only a  narrative synthesis was 102 
perfomed.14 Since the publication of these reviews, there have been a number of additional 103 
studies published. To provide a clearer and comprehensive picture of the underlying 104 
evidence, we undertook a systematic review with meta-analysis of studies that have 105 
investigated the association between prenatal maternal exposure to psychosocial stress and 106 
the risk of asthma and allergy in the offspring. We included the full spectrum of asthma and 107 
allergy outcomes and were also interested in understanding whether the type of indicator of 108 
prenatal psychosocial stress and timing (trimester) of exposure were important. 109 
 110 
METHODS 111 
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We published15 and registered in PROSPERO (registration number:  112 
2016:CRD42016036456) the protocol for the review prior to commencement of the 113 
systematic review, which outlined the approaches to undertaking the review. 114 
 115 
Study types 116 
Experimental studies (i.e. randomized-controlled trials, quasi-randomized controlled trials, 117 
controlled-clinical trials, controlled before-and-after studies, interrupted time-series designs) 118 
and analytical epidemiological studies (cohort, case-control, and cross-sectional studies) 119 
were eligible for inclusion. We excluded reviews, case-studies, case-series, and animal 120 
studies. 121 
 122 
Participants 123 
Pregnant women and their offspring of any age. 124 
 125 
Exposure 126 
We included all indicators of psychosocial stress, mood states, and acute or chronic 127 
stressors or negative life events (NLEs), including: anxiety and depression, issues with 128 
existing children, exposure to violence, discrimination or prejudice, financial problems, 129 
residential move or housing issues, daily stressors or generalized psychological distress, 130 
bereavement, natural disasters, separation, divorce or marital problems, involuntary job loss 131 
for mother or partner, and homelessness. We included studies with either objectively-132 
measured or subjectively-reported measures of the stress events. 133 
 134 
Outcomes 135 
Primary outcomes were: asthma, atopic dermatitis/eczema, atopic sensitization, food allergy, 136 
allergic rhinitis, urticaria and anaphylaxis. All primary outcomes, with the exception of atopic 137 
sensitization, were defined either by physician assessment or by the self-report. Additionally, 138 
asthma diagnosis through use of airway function tests including peak expiratory flow [PEF], 139 
forced expiratory volume in 1 second [FEV1], forced vital capacity [FVC], forced expiratory 140 
flow rate or alternative age appropriate pulmonary function tests [oscillometry or exhaled 141 
nitric oxide analysis] were also accepted methods of assessment. Secondary outcomes 142 
included: asthma exacerbations, use of asthma medications, hospitalization for asthma, 143 
wheeze as defined by self-report or physician diagnosis, and measures of Health Related 144 
Quality of Life (HRQoL). 145 
 146 
Study identification 147 
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We searched the following databases from 1960 to the end of 2016: MEDLINE,  EMBASE, 148 
Cochrane Library, Web of Science, Scopus,  Global Health and Cab International;  WHO 149 
Global Library; Psych INFO, CINAHL, AHMED, National Health Service (NHS) Evidence 150 
Health Information Resources, and Google Scholar. The following databases for international 151 
conference proceedings were also searched: Conference Proceedings Citation Index via 152 
Web of Knowledge and Zetoc via British Library. Reference lists of eligible articles were hand 153 
checked for additional citations. International experts in the field were contacted to ask for 154 
any relevant studies not captured through our database searches. We also searched the 155 
grey literature through Open Grey and The Grey Literature Report. Finally, the following 156 
registers were searched to locate ongoing studies: The Cochrane Central Register of 157 
Controlled Trials, International Standardized Randomized Control Trial Number Registry, 158 
WHO International Clinical Trials Registry Platform, ClinicalTrials.gov, Australian and New 159 
Zealand Clinic Trials Registry, and Current Controlled Trials. There was no language 160 
restriction. The search strategies were published in our systematic review protocol.15    161 
 162 
Study selection 163 
Records retrieved from the databases were exported to Endnote for study screening, de-164 
duplication, and overall management of the retrieved records. Study titles and abstracts were 165 
independently screened by two reviewers (CF and BN); any discrepancies were resolved by 166 
discussion. The same process was employed for full-text screening. Multiple reports based 167 
on the same study were reported as one study. Where data or information was missing from 168 
any study, we contacted authors requesting additional information. 169 
 170 
Data extraction and management 171 
A standardized form was developed and used to extract relevant data from each study. The 172 
data extraction form was piloted and revised prior to use in the review and was published 173 
alongside the protocol for this study.15 Data extraction was completed independently by two 174 
reviewers (CF and BN) and discrepancies were resolved by discussion. 175 
 176 
Quality assessment 177 
All included studies were assessed for quality and risk of bias by two independent reviewers 178 
(CF and BN) using the Effective Public Health Practice Project (EPHPP) tool 179 
(http://www.ephpp.ca/tools.html). In addition to a global rating for each study, the EPHPP tool 180 
provides individual ratings for six domains of study quality, including appropriateness of study 181 
design for the research question, selection bias, exposure assessment, outcome 182 
assessment, data analysis, and generalizability of findings. The two reviewers graded the 183 
quality of each study with regards to each of these domains. The quality grading derived from 184 
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each of the domains informed an overall grading for each study. For each study, the grading 185 
for the domains individually and the global study rating were assigned one of the three 186 
categories of risk of bias: weak, moderate, or strong. Concerning the domain on confounder 187 
adjustment, we considered the number and type of potential confounders adjusted in the 188 
studies, with close attention to the confounding factors listed in our own causal diagram (see 189 
Figure S1).  190 
 191 
Analysis 192 
We tabulated the features and key findings of the studies in order to provide a descriptive 193 
summary of the literature. We employed both narrative and quantitative synthesis of the 194 
underlying evidence. The quantitative synthesis (meta-analysis) was undertaken for studies 195 
judged to be reasonably homogenous with regards to similarity in the clinical, 196 
methodological, and statistical aspects. We used the random-effects meta-analysis approach 197 
for this purpose and included the adjusted risk estimates from each study. We included only 198 
cohort studies in the meta-analyses and not  cross-sectional and case-control studies. 199 
Studies reporting odds ratios as effect measures were first converted to risk ratios before 200 
combining in meta-analyses with studies reporting risk ratios. Conversion of odds ratios to 201 
risk ratios was undertaken using the formulae by Grant, which given as follows: RR = OR/(1-202 
p0+(p0 x OR)); where p0 is the baseline risk.16 We quantified heterogeneity between studies 203 
using the I2 test. We performed the following stratified analyses for each outcome: by type of 204 
stress indicator and timing (trimester) of exposure during pregnancy. To enhance 205 
comparability between studies that categorized any of the exposures as binary, we collapsed 206 
estimates from exposure categories in studies that used multiple exposure categories by 207 
using the Mantel-Haenszel approach,17 thus in all analyses we estimated the risk of maternal 208 
stress versus no stress: we estimated the role of maternal exposure to any type of stress 209 
indicator (i.e. any of the studied stressors – anxiety, depression, bereavement, work-related 210 
stress, or NLEs), specific stress indicators, and trimester of exposure in relation to the 211 
outcomes. We used funnel plots to evaluate the potential for publication bias and small study 212 
effects and calculated the Begg and Egger’s test for this purpose.18 Meta-analysis was 213 
undertaken using Stata 14 statistical software. 214 
 215 
RESULTS 216 
In total, we identified 9779 articles, of which 7110 were included for screening by title and/or 217 
abstract after de-duplication. Of these, 7001 were excluded for not meeting the inclusion 218 
criteria and 109 articles were assessed for full text screening. A further 77 articles were 219 
excluded, leaving 32 articles (based on 30 studies) that met our inclusion criteria for narrative 220 
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synthesis; 24 papers (based on 22 studies) were included in at least one meta-analysis 221 
(Figure 1).19-50 222 
 223 
Study characteristics 224 
The key characteristics of the studies are presented in Table E1. No experimental studies 225 
were found; therefore only analytical epidemiological studies were included, which comprised 226 
of 27 cohort studies, two case-control studies, and one cross-sectional study. The type of 227 
psychosocial stress indicators investigated in the studies included anxiety,21-24,27,30,35,36,48,49 228 
depression,22-24,30,35,37,41,42 bereavemet,29,32,38 work-related stress,33,36,47,48 and 229 
NLEs,19,20,25,26,28,31,34,39,40,43-46,49,50 which were usually comprised of a composite of different 230 
indicators of stressors. Most studies assessed maternal stress using self-completed 231 
validated questionnaire; in a few studies maternal stress was assessed from population 232 
registers, particularly stress resulting from bereavement of a family member. Twelve studies 233 
assessed the impact of maternal stress on asthma,20,27-32,34,37,38,42,46 eight studies on atopic 234 
eczema/dermatitis,22-24,28,31,44,47,48 ten studies on wheeze,20,24-28,30,35,42,43,46 three studies on 235 
allergic rhinitis,24,28,31 three on atopic sensitization,27,31,42 and six studies on cord blood IgE or 236 
cytokines19,21,36,39,45,50   (Table S1). 237 
 238 
Risk of bias within studies 239 
Table S2 provides details of the quality grading for the studies. Of the 30 studies graded for 240 
quality, four were strong, 25 were moderate, and one study was weak. Whilst all studies 241 
scored moderate or strong on exposure and outcome assessment, only one study scored 242 
weak on study design as it was based on a cross-sectional data. Six studies were graded 243 
weak for selection bias, whereas two studies were graded weak for confounding adjustment; 244 
no study was graded strong for selection bias and confounding adjustment. 245 
 246 
Prenatal stress and offspring asthma 247 
Prenatal maternal exposure to any type of stress indicator was associated with an increased 248 
risk of asthma onset (hazard ratio (HR) 1.13, 95%CI 0.98-1.32; I2=91.5%) and current or ever 249 
asthma (RR 1.13, 95%CI 1.03-1.24; I2=83.5%) in the offspring, although result for asthma 250 
onset was not statistically significant (Figure 2, Panel A). Concerning the type of stress 251 
indicators, only anxiety was significantly associated with an increased risk of asthma (RR 252 
1.28, 95%CI 1.16-1.41; I2=0%) (Figure 2, Panel B). Concerning the timing of prenatal 253 
maternal stress, only exposure during the third trimester was significantly associated with an 254 
increased risk of asthma (OR 1.45, 95%CI 1.08-1.94; I2=78%) for the studies that measured 255 
current and ever asthma (Figure 3, Panel B). Bereavement of the death of a child (HR 1.28, 256 
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95%CI 1.10-1.48; I2=0%) or of a spouse (HR 1.40, 95%CI 1.03-1.90; I2=1.3%), but not of a 257 
parent or sibling, increased the risk of asthma onset in the offspring (Figure 4). 258 
 259 
Prenatal stress and offspring atopic eczema/dermatitis  260 
Prenatal maternal exposure to anxiety (RR1.29, 95%CI 0.95-1.76; I2=29.2%), depression 261 
(RR 1.45, 95%CI 1.12-1.89; I2=0%), NLEs (OR 1.18, 95%CI 0.92-1.51; I2=0%), and work 262 
stress (OR 1.32, 95%CI 1.16-1.50) was associated with increased risk of atopic 263 
eczema/dermatitis in the offspring, but only depression and work stress were statistically 264 
significant (Figure 5, Panel A). Maternal exposure to stress during the third and any 265 
trimester, but not during the second trimester, increased the risk of offspring atopic 266 
eczema/dermatitis (Figure 5, Panel B). 267 
 268 
Prenatal stress and offspring wheeze  269 
Prenatal maternal exposure to anxiety (RR 1.19, 95%CI 1.01-1.39; I2=52%), depression (OR 270 
1.74, 95%CI 1.42-2.13; I2=0%), and NLEs (RR 1.23, 95%CI 1.00-1.52; I2=88.3%) (Figure 6, 271 
Panel A) was associated with an increased risk of wheeze in the offspring. The increased 272 
risk was greater for maternal exposure to stress during the second and third than any 273 
trimester (Figure 6, Panel B). When we investigated the impact on different wheezing 274 
phenotypes, maternal stress increased the risk of early-onset, late-onset, and persistent 275 
wheeze, although the impact on late-onset wheeze was not statistically significant (Figure 7). 276 
 277 
Prenatal stress and offspring allergic rhinitis 278 
Prenatal maternal exposure to any type of stress indicator was associated with an increased 279 
risk of subsequent allergic rhinitis in the offspring (OR 1.36, 95%CI 1.08-1.71; I2=43.7%) 280 
(Figure S2). These results were similar when the study by Hartwig et al was analyzed 281 
separately for allergic rhinitis at six and 14 years.31 282 
 283 
Prenatal stress and offspring atopic sensitization  284 
Prenatal maternal exposure to any stress indicator was associated with a decreased risk of 285 
atopic sensitization in the offspring (OR 0.92, 95%CI 0.86-0.98; I2=0%) (Figure 8). These 286 
results were similar when the study by Hartwig et al was analyzed separately for atopic 287 
sensitization at six and 14 years.31 The measurement and definition of atopic sensitization 288 
differed between the studies: whilst Cookson27 defined it as ≥2 mm weal skin prick test to 289 
aeroallergens, Hartwig31 and Reyes42 were based on IgE measurements of a combination of 290 
both food and inhalant allergens. 291 
 292 
Prenatal stress and cord blood IgE and cytokines 293 
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Studies reporting the impact of maternal prenatal stress on cord blood IgE and cytokines 294 
were heterogeneous, particularly with regards to the type of outcomes investigated, hence a 295 
meta-analysis was not undertaken to pool the results of these studies together. However, 296 
across studies, maternal exposure to stress during pregnancy was associated with raised 297 
cord blood specific and total IgE.36,39,45,50 One study reported an alteration of cord blood 298 
cytokine profiles (IL-12, IL-1β, IL-4, IL-5, IL6, IL-8, and TNF-α) in offspring of mothers 299 
exposed to stress during pregnancy.19 300 
 301 
Assessment of publication bias 302 
Figure S3 shows the funnel plot evaluating possible publication bias and small study effect: 303 
by interpretation, a symmetric funnel plot indicates less likelihood of publication bias 304 
influencing the estimates of effect. Indeed, the funnel plot in Figure S3 is modestly 305 
symmetric. The associated p-values for Egger’s test (where Egger’s test of with P<0.05 306 
indicating presence of publication bias) were as follows: atopic eczema/dermatitis studies 307 
p=0.949; atopic sensitization studies p=0.855; wheeze studies p<0.001; asthma studies 308 
p=0.828; and allergic rhinitis studies p=0.493.  309 
 310 
DISCUSSION 311 
This study provides the most comprehensive and robust synthesis of the evidence to date on 312 
the association between prenatal maternal exposure to psychosocial stress and the risk of 313 
allergy and asthma in the offspring. The majority of included studies were at moderate risk of 314 
bias. Overall, prenatal maternal exposure to any psychosocial stress was associated, albeit 315 
modestly, with an increased risk of asthma, atopic eczema/dermatitis, wheeze and its 316 
phenotypes, and allergic rhinitis. A decreased risk was seen for atopic sensitization. Although 317 
these results were similar for specific indicators of stress, exposure to anxiety and 318 
depression had the strongest effects. The third trimester appeared to be more vulnerable 319 
period of exposure compared to first and second trimesters. Specific to asthma, maternal 320 
bereavement of a child or a spouse, but not of a parent or sibling, increased the risk of 321 
asthma in the offspring.  322 
 323 
We undertook an exhaustive search of the literature, covering the major medical and public 324 
health databases, which was supplemented through search of grey literature and through 325 
contacting experts in the field. The search strategies were implemented and published in 326 
order to enhance reproducibility. It is therefore unlikely that we missed any relevant literature, 327 
this being confirmed by somewhat symmetric funnel plot on publication bias and small study 328 
effect. Two reviewers independently performed each stage of the review, including literature 329 
screening, data extraction, and quality appraisal of included studies. We developed, 330 
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published and registered a detailed protocol15 prior to undertaking the review, which 331 
enhanced the transparency of the review process.  332 
 333 
At the same time of publishing our review protocol, two related systematic reviews were 334 
published.13,14 By the time we were planning the current review, no protocol was published 335 
for those reviews, neither were they registered in PROSPERO; hence our preliminary search 336 
did not identify them. Nevertheless, in the first review only asthma and wheeze were 337 
outcomes, which limits its scope.13 The second review considered all possible asthma and 338 
allergic outcomes, but only provided narrative synthesis of the existing literature.14 We aimed 339 
for a comprehensive and exhaustive approach by including the full spectrum of allergy and 340 
asthma outcomes and considering whether the type of stressor and trimester of exposure 341 
were important. We identified 30 unique studies as against 16 studies in the second review14 342 
and 18 studies as against 10 studies in the first review with regards to asthma/wheeze 343 
outcomes.13 Whilst the second study14 performed only narrative synthesis, with careful 344 
consideration, we judged several of these studies to be reasonably homogenous to be 345 
combined in meta-analyses with respect to exposure and outcome definitions, study design, 346 
and statistical analyses. Regardless of the differences in methodological rigor and 347 
comprehensiveness, the conclusions from the two previous systematic reviews align with our 348 
findings, indicating that prenatal maternal exposure to psychosocial stress was associated 349 
with increased risk of asthma and allergic disease in the offspring. 350 
 351 
The majority of studies included in our review were graded as at moderate risk of bias, with 352 
only four being graded as strong studies, an indication of the potential for biases across 353 
studies, particularly within the domains of selection bias and confounding adjustment. In 354 
particular, most studies assessed maternal prenatal stress using self-report questionnaires, 355 
usually for recall of previous exposure to stress across several months. No study used both 356 
self-report and objective measures at regular intervals, which would provide a more robust 357 
and informative understanding of unique and combined contribution of environmental and 358 
mechanistic factors involved in the developmental pathway of atopic conditions. Several 359 
studies also assessed allergy outcomes using maternal subjective questionnaires and the 360 
age of onset of the outcomes was not consistent across all studies. Objective assessment of 361 
both maternal prenatal stress and offspring outcomes and within the same time-point will 362 
improve the underlying evidence and provide a stronger basis to evaluate whether these 363 
findings are causal.14 The test for heterogeneity was significant for a number of associations, 364 
an indication of the variations in methods and measures between studies; however as we did 365 
not have sufficient number of studies for each of these associations, we were unable to 366 
further investigate the possible reasons for these significant heterogeneity tests. 367 
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Furthermore, as it was not feasible to perform a formal test between subgroups, it is possible 368 
that the associations found within subgroups may be a result of chance. 369 
 370 
Although some studies have examined the role of maternal stress during the postpartum 371 
period and the child’s exposure during infancy on subsequent risk of allergy and asthma in 372 
the child,26,51 a priori,15 the underpinning objective of our review was to assess the impact of 373 
prenatal stress on offspring’s asthma and allergy. This objective aligns within the framework 374 
of the fetal programming hypothesis. Within this framework, we assumed that the pathway of 375 
prenatal stress influencing offspring asthma and allergy risk may be independent of the 376 
effects of postnatal and early life stress, hence we excluded all studies not investigating 377 
maternal prenatal stress. However, we cannot rule out the possibility that these findings may 378 
also be partly explained by postnatal or early life stress exposures.52 Furthermore, whilst the 379 
timing of exposure was based on the trimester of assessment of prenatal stress, this single 380 
time-point assessment may fail to reflect specific trimester effect, as stressful events may be 381 
acute or may chronologically be present throughout pregnancy or may even be an extension 382 
of stressful events prior to pregnancy.52  383 
 384 
Regardless of the type of stress indicator, timing of exposure, and the type of allergy and 385 
asthma outcomes, by bringing together all the available evidence, the current evidence 386 
synthesis shows that prenatal maternal psychosocial stress is associated with an increased, 387 
albeit modest, risk of asthma and allergy in the offspring. The findings were particularly more 388 
evident for depression and anxiety than for other indicators of prenatal stress. This could 389 
reflect that anxiety and depression scores were based on self-assessment and 390 
questionnaires. However, it should also be noted that the largest study had a strongly 391 
positive result.32 This study also had a strong design due to using a ‘natural experiment’ 392 
design and an objective measure of hospitalized asthma, thereby avoiding the risks of 393 
reporting bias and reverse causation.32 In addition, although depression and anxiety reflect 394 
mood states, they are robust correlates of psychosocial stress and strongly predispose to 395 
stress-related conditions, such as smoking, poor diet, poor sleeping habits, and poor quality 396 
of life which may also lead to asthma and allergy in offspring.53  397 
 398 
Whilst our observations may represent causal relationships, they may also be a 399 
consequence of over-reporting of offspring disease status by distressed mothers22,54or due to 400 
residual confounding in the original studies. The number and type of confounders adjusted 401 
varied across included studies. In particular, the omission of key confounders in several 402 
studies, including maternal allergic history, pregnancy complications, acid reflux conditions, 403 
medication use during pregnancy (e.g. antibiotics and acetaminophen), and pregnancy 404 
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weight gain indicates sub-optimal confounding adjustment and therefore may impact on the 405 
observed risk. One way to test for residual confounding in fetal programming studies is to 406 
use family design studies such as sibling studies54,55 or to use a paternal negative control. A 407 
positive association for paternal exposure to stress during the mother’s pregnancy and 408 
subsequent offspring asthma or allergy may indicate residual confounding is affecting the 409 
prenatal maternal stress and offspring asthma association. A recent study using fathers as a 410 
negative control in this way, found that after adjusting for measured confounders there was 411 
no evidence for residual confounding.56       412 
 413 
One hypothesized pathway through which stress may influence risk of asthma and allergy is 414 
that high levels of cortisol resulting from external stress may potentiate cell differentiation 415 
from Th1 to Th2 phenotype.12 Prenatal stress-generated cortisol has been linked to 416 
increased airway responsiveness in the offspring in animal models.12 This indicates that 417 
prenatal maternal stress may increase risk of atopic sensitization in the offspring and 418 
subsequent allergic disease and asthma. However, our findings did not support this line of 419 
reasoning, but showed a decreased risk of atopic sensitization and increased risk of clinical 420 
allergic outcomes and asthma. The reason for these differential findings between atopic 421 
sensitization and other clinical outcomes is unclear. Other suggested mechanism indicate 422 
that prenatal maternal stress may cause epigenetic effects with deoxyribonucleic acid (DNA) 423 
methylation and altered gene expression in the placenta,57 but this proposal and its 424 
implication for the development of allergy and asthma in the offspring has yet to be 425 
determined.51 There is some evidence that prenatal stress exposure can influence the 426 
composition of the offspring’s intestinal microbiota and may also result in increased 427 
susceptibility to asthma.58,59  428 
 429 
CONCLUSION 430 
Prenatal maternal psychosocial stress – particularly anxiety and depression - was associated 431 
with a modest increased risk of asthma and allergy in the offspring. Whilst exposure during 432 
the third trimester had the greatest impact compared to the first and second trimesters, this 433 
may represent cumulative stress exposure throughout pregnancy rather than a trimester-434 
specific effect. These findings may represent a causal association; they may also result from 435 
inherent biases in the included studies, particularly residual confounding. Further studies with 436 
objective measures of prenatal stress and optimal adjustment of confounding are required, 437 
as well as studies elucidating the likely mechanisms for these associations. 438 
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Figure 1. PRISMA flow diagram of studies on the association between maternal prenatal 
stress and risk of allergy and asthma in the offspring 
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PANEL A 
 
 
 
 
 
PANEL B 
 
 
 
 
 
Figure 2. Association between prenatal maternal stress (Panel A: any type of stress and Panel B by type of stress) and risk of asthma in the 
offspring. NLEs = Negative life events. The results included Hartwig 2014 and Liu 2016 populations of 14 years and 4-15 years, respectively, 
as these were not substantially different from the population of 6 years and 0-3 years, respectively, also presented in the studies. 
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PANEL A 
 
 
 
 
 
 
PANEL B 
 
 
 
Figure 3. Association between prenatal maternal stress and risk of asthma in the offspring, by timing of exposure during pregnancy: 
Panel A: during any trimester; Panel B: at different trimesters. The results included Hartwig 2014 and Liu 2016 population of 14 
years and 4-15 years as these were not substantially different from the population of 6 years and 0-3 years also presented in the 
studies. 
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Figure 4. Association between maternal stress resulting from bereavement of a relative 
and risk of asthma in the offspring, by type relative. The results included Hartwig 2014 and 
Liu 2016 population of 14 years and 4-15 years as these were not substantially different 
from the population of 6 years and 0-3 years also presented in the studies. 
5 
 
PANEL A 
 
 
 
 
 
PANEL B 
 
 
 
 
 
Figure 5. Association between maternal prenatal stress and risk of atopic eczema/dermatitis in the offspring, by type of stress (Panel 
A) and timing of exposure during pregnancy (Panel B). NLEs = negative live events. No major differences when Hartwig 2014’s 6-
year-olds and 14-year-olds were analysed separately, hence we presented the results for 6-year-olds 
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PANEL A 
 
 
 
 
 
 
 
PANEL B 
 
 
 
 
 
 
 
Figure 6. Association between maternal prenatal stress and risk of wheeze in the offspring, by type of stress (Panel A) and timing of 
exposure during pregnancy (Panel B). NLEs = negative live events. No major differences when Cookson 2009’s wheeze at 6-18 
months and 69-81 months were analysed separately, hence we present the results for the 6-18 month age group 
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Figure 7. Association between maternal prenatal stress and risk of wheeze phenotypes in 
the offspring 
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Figure 8. Association between maternal prenatal stress and atopic sensitisation in the 
offspring, by timing of exposure during pregnancy: No major differences when Hartwig 2014’s 
6-year-olds and 14-year-olds were analysed separately, hence we presented the results for 6-
year-olds 
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Table S1: Main characteristics, key results, and overall risk of bias of studies on the association between maternal psychosocial 
stress during pregnancy and risk of allergy and asthma in the offspring 
 
Reference, country; and 
study design 
Study population 
N (maternal-child; source of 
study population) 
 
Age of 
children/ 
follow-up 
years 
 
 
Type of prenatal stress 
and assessment 
 
Outcomes and 
assessment  
 
 
Key results  
 
 
Overall 
risk of bias 
assessment Number 
recruited 
Number 
analysed 
Andersson et al 2016; USA; 
Prospective cohort study 
50 43 At birth Maternal reported anxiety 
and negative life events 
(NLEs) during the 2
nd
 
trimester using Self-
reported using Perceived 
Stress Scale (PSS-14); 
State-Trait anxiety 
inventory (STAI); Life 
Experience Interview 
 
Cord blood 
cytokines: IL-12, 
IL-1β, IL-4, IL-5, 
IL6, IL-8, and 
TNF-α 
Prenatal maternal stress increased the risk of 
alteration of cord blood cytokine profiles in the 
offspring 
Moderate 
Bandoli et al 2016; USA; 
Prospective cohort study 
6,347 1,193 2.3-5.8 years Maternal reported 
anxiety, chronic stress, 
and NLEs (loss of 
car/job/home, serious 
arguments with partner, 
close acquaintance with 
health, drug or legal 
problems, death of a 
relative, threatened with 
physical harm, 
discrimination due to 
race/ethnicity) at any time 
during pregnancy 
 
Maternal reported 
wheeze and 
asthma using the 
ISAAC 
questionnaire 
Maternal anxiety and current asthma: adjusted 
  Moderate vs none: RR 1.22 (0.73-2.05) 
  Somewhat vs none: RR 1.07 (0.67-1.71) 
  Very much vs none: RR 1.39 (0.83-2.35) 
Maternal chronic stress and current asthma: adjusted 
  Moderate vs low: RR 0.75 (0.49-1.14) 
  High vs low: RR 1.11 (0.67-1.86) 
Maternal NLEs and current asthma: adjusted 
  1 NLE vs none: RR 1.21 (0.80-1.83) 
  2+ NLEs vs none: RR 0.96 (0.58-1.57) 
Results also given in the paper for ever and current 
wheeze  
Moderate  
Bidaki et al 2011; Iran; 
Prospective cohort study 
320 290 At birth Maternal reported 
anxiety. Assessed using 
the Holme-Rahe stress 
questionnaire at the 3
rd
 
trimester of pregnancy 
Cord blood IgE No estimate of effect computed only descriptive data 
presented in the paper 
Moderate 
Braig et al 2016; Germany; 
Prospective cohort study 
2,610 787 Up to 2 
years 
Maternal questionnaire-
reported chronic stress, 
anxiety, and depression 
symptoms during the 3
rd
 
trimester. Also maternal 
hair cortisol 
Maternal 
questionnaire-
reported atopic 
dermatitis (AD). 
Dermatologist 
confirmation using 
Maternal chronic stress and AD symptoms: adjusted 
  Quartile 2 vs quartile 1: RR 1.3 (0.8-1.9) 
  Quartile 3 vs quartile 1: RR 1.4 (0.9-2.1) 
  Quartile 4 vs quartile 1: RR 1.5 (1.0-2.3) 
Maternal depression and AD symptoms : adjusted 
  High vs low: RR 1.4 (1.0-2.0) 
Moderate 
2 
 
SCORAD Maternal anxiety and AD symptoms: adjusted 
  Quartile 2 vs quartile 1: RR 1.4 (0.9-2.1) 
  Quartile 3 vs quartile 1: RR 1.4 (0.9-2.2) 
  Quartile 4 vs quartile 1: RR 1.5 (0.9-2.4) 
Maternal hair cortisol and AD symptoms: adjusted 
  Quartile 2 vs quartile 1: RR 1.0 (0.7-1.5) 
  Quartile 3 vs quartile 1: RR 0.9 (0.6-1.4) 
  Quartile 4 vs quartile 1: RR 0.8 (0.5-1.2) 
Results also given in the paper for parent-reported, 
paediatrician-reported and strictly defined AD 
 
Chang et al 2016; South 
Korea; Prospective cohort 
study 
Cohort 1: 2,021 
Cohort 2: 2,150 
Cohort 1: 973 
Cohort 2: 
1,531 
Up to 5 
years 
Maternal questionnaire-
reported stress: 
Cohort 1: depression and 
anxiety at 3
rd
 trimester 
Cohort 2: depression any 
time during pregnancy 
 
AD symptoms 
Cohort 1:  
diagnosis by 
pediatric allergist 
Cohort 2: 
maternal report 
using ISAAC 
questionnaire 
 
Cohort 1: maternal depression and AD: adjusted 
   HR 1.31 (1.02-1.69) 
Cohort 1: maternal anxiety and AD: adjusted 
   HR 1.41 (1.06-1.89) 
Cohort 2: maternal depression and AD: adjusted 
  OR 1.85 (1.06-3.25) 
Moderate 
Cheng et al 2015; 
Singapore; Prospective 
cohort study 
1,152 1,067 Up to 1 year Maternal questionnaire-
reported depression 
(using Edinburgh 
Postnatal Depression 
Scale) and anxiety 
(State-Trait Anxiety 
Inventory) during 2
nd
 
trimester 
 
Maternal reported 
doctor-diagnosed 
wheeze, allergic 
rhinitis, and atopic 
eczema 
Maternal depression: adjusted 
   Wheeze: OR 2.09 (1.05-4.19) 
   Allergic rhinitis: OR 1.13 (0.54-2.36) 
   Atopic eczema: OR 1.13 (0.43-    2.99) 
Maternal anxiety state: adjusted 
   Wheeze: OR 1.01 (0.63-1.61) 
   Allergic rhinitis: OR 1.82 (1.17-2.82) 
   Atopic eczema: OR 1.01 (0.56-1.81) 
Maternal anxiety trait: adjusted 
   Wheeze: OR 1.23 (0.78-1.94) 
   Allergic rhinitis: OR 1.70 (1.10-2.61) 
   Atopic eczema: OR 1.02 (0.58-1.81) 
 
Moderate 
Chiu et al 2012; Chiu et al 
2014; USA; Prospective 
cohort study 
 
989 653 for Chiu 
2012 ; 
 
708 for Chiu 
2014 
 
 
Up to 2 
years 
Maternal reported 11 
domains of NLEs – e.g. 
financial, relationships, 
violence, other housing 
issues, and 
discrimination and 
prejudice; exposure to 
community violence 
(ECV). Assessed through 
self-report at 3
rd
 trimester 
 
Maternal 
questionnaire-
reported wheeze 
in the offspring up 
to 2 years of age 
NLEs and wheeze: adjusted 
  1-2 vs none: OR 1.95 (0.76-5.00) 
  3-4 vs none: OR 3.55 (1.38-9.15) 
  5+ vs none: OR 3.79 (1.39-10.3) 
ECVs scores and wheeze: adjusted  
  Medium vs low: OR 1.34   (0.71-2.52) 
  High  vs low: OR 1.95 (1.13-3.36) 
 
 
Moderate 
Cookson et al 2009; UK; 
Prospective cohort study 
14,062 5,810 Up to 7.5 
years 
Maternal anxiety reported 
using the Crown-Crisp 
Maternal 
questionnaire-
Anxiety at 18 weeks and current asthma: adjusted 
  2
nd
 vs 1
st
 quart. OR 1.24 (1.00-1.55) 
Moderate 
3 
 
Experimental Index. 
Assessed at 18 and 32 
weeks pregnancy 
reported doctor-
diagnosed current 
asthma and 
consultation for 
wheeze. Specific 
IgE sensitisation; 
and methacholine-
based 
bronchohyper-
responsiveness 
(BHR) 
 
  3
rd
 vs 1
st
 quart. OR 1.32 (1.07-1.63) 
  4
th
 vs 1
st
 quart. OR 1.53 (1.22-1.93) 
Anxiety at 32 weeks and current asthma: adjusted 
  2
nd
 vs 1
st
 quart. OR 1.36 (1.09-1.71) 
  3
rd
 vs 1
st
 quart. OR 1.42 (1.14-1.77) 
  4
th
 vs 1
st
 quart. OR 1.65 (1.30-2.08) 
 
Results also given in the paper for wheeze at 18 and 
81 months; atopic and non-atopic asthma, asthma + 
BHR; BHR, and atopic sensitisation 
 
de Marco et al 2012; Italy; 
Cross-sectional study 
3,907 3,758 3-14 years 
(mean 8.5 
years) 
Maternal NLEs 
(mourning, loss of own or 
husband’s job, 
separation, divorce). Self-
reported questionnaire. 
Assessed for events 
occurring during any 
trimester 
 
Maternal 
questionnaire-
reported ever 
asthma, wheeze, 
atopic eczema, 
and allergic 
rhinitis 
Exposure to any NLEs: adjusted 
   Asthma: OR 1.71 (1.02-2.89) 
   Wheeze: OR 1.41 (1.03-1.94) 
   Atopic eczema: OR 1.53 (1.11-2.10) 
   Allergic rhinitis: OR 1.75 (1.08-2.84) 
Moderate 
Fang et al 2011; Sweden; 
Retrospective cohort study 
Cohort 1 (born 
2004-2008): 
449,363 
 
Cohort 2 (born 
1997-2002): 
514,261 
Cohort 1: 
426,334 
 
Cohort 2: 
493,813 
 
Cohort 1: up 
to 4 years 
Cohort 2: 7-
12 years 
Maternal bereavement. 
Assessed from 
population register. For 
bereavement ≤1 year 
before pregnancy and at 
different trimesters 
Cohort 1: incident 
asthma  
Cohort 2: current 
asthma 
Assessed from 
disease register 
Cohort 1: bereavement and asthma onset :adjusted 
  Any time during pregnancy: HR 1.00 (0.87-1.14) 
  1
st
 trimester: HR 0.98 (0.76-1.27) 
  2
nd
 trimester: HR 1.18 (0.94-1.48) 
  3
rd
 trimester: HR 0.87 (0.70-1.09) 
Cohort 2: bereavement and current asthma: adjusted 
  Any time during pregnancy: OR 0.99 (0.84-1.17) 
  1
st
 trimester: OR 1.02 (0.76-1.37) 
  2
nd
 trimester: OR 0.86 (0.63-1.18) 
  3
rd
 trimester: OR 1.07 (0.84-1.39) 
Estimates reported in the paper also separately for 
boys and girls; also by relative type, and by cause of 
death 
   
Strong 
Guxens et al 2014; 
Netherlands; Prospective 
cohort study 
8,880 4,848 Up to 6 
years 
Maternal reported 
depression and anxiety 
symptoms during the 2
nd
 
trimester 
Maternal 
questionnaire-
reported doctor-
diagnosed ever 
asthma at 6 years 
and wheeze at 4 
years 
Exposure to anxiety + depression: adjusted 
  Ever asthma: OR 1.45 (0.91-2.31) 
  Early wheeze (≤3 yrs): OR 1.23 (0.89-1.69) 
  Late wheeze (at 4 yrs): OR 1.94 (1.04-3.60) 
  Persistent wheeze (1-4 yrs): OR 2.15 (1.47-3.13) 
Exposure to depression: adjusted 
  Ever asthma: OR 1.33 (0.82-2.16) 
  Early wheeze (≤3 yrs): OR 1.31 (0.97-1.76) 
  Late wheeze (at 4 yrs): OR 2.04 (1.14-3.64) 
  Persistent wheeze (1-4 yrs): OR 1.84 (1.24-2.72) 
Exposure to anxiety: adjusted 
Moderate 
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  Ever asthma: OR 1.19 (0.76-1.86) 
  Early wheeze (≤3 yrs): OR 1.17 (0.88-1.55) 
  Late wheeze (at 4 yrs): OR 1.81 (1.05-3.12) 
  Persistent wheeze (1-4 yrs): OR 1.72 (1.22-2.43) 
 
Hartwig et al 2014; Australia; 
Prospective cohort study 
2,860 994 14 years Maternal reported 10 
NLEs including 
separation or divorce, 
marital problems, 
problems with children, 
pregnancy problems, 
experience of involuntary 
job loss, partner 
experienced involuntary 
job loss, money 
problems, a residential 
move, death of a close 
relative, and death of a 
close friend. Assessed 
for events occurring ≤18 
and 18-34 weeks of 
pregnancy  
Maternal 
questionnaire 
reported current 
asthma, allergic 
rhinitis, and atopic 
eczema. At 6 and 
14 years Atopic 
sensitisation also 
assessed at 6 and 
14 years 
Exposure to NLEs by 18 weeks: adjusted 
  Asthma at 6 years: 
    1 vs no NLEs: OR 1.30 (0.86-1.95) 
    2 vs no NLEs: OR 1.21 (0.72-2.04) 
    3+ vs no NLEs: OR 1.73 (0.87-3.44) 
  Asthma at 14 years: 
    1 vs no NLEs: OR 1.12 (0.67-1.87) 
    2 vs no NLEs: OR 1.08 (0.56-2.07) 
    3+ vs no NLEs: OR 1.26 (0.54-2.91) 
Exposure to NLEs by 34 weeks: adjusted 
  Asthma at 6 years: 
    1 vs no NLEs: OR 1.10 (0.72-1.66) 
    2 vs no NLEs: OR 1.34 (0.80-2.24) 
    3+ vs no NLEs: OR 0.99 (0.47-2.08) 
  Asthma at 14 years: 
    1 vs no NLEs: OR 2.24 (1.33-3.75) 
    2 vs no NLEs: OR 1.96 (1.01-3.79) 
    3+ vs no NLEs: OR 1.81 (0.74-4.46) 
Estimated also reported in the paper for allergic 
rhinitis, atopic eczema, and atopic sensitisation and 
by maternal history of asthma 
 
Moderate 
Khashan et al 2012; 
Sweden; Retrospective 
cohort study 
3,290,141 3,193,033 Up to 2-34 
years 
Bereavement (death of a 
spouse or child) during 
the 1
st
, 2
nd
 and 3
rd
 
trimester. Assessed from 
population register 
 
Asthma 
hospitalisation 
and asthma 
hospitalisation pus 
other related 
outcomes 
(bronchitis, 
COPD, allergic 
rhinitis, atopic 
dermatitis, ALRI). 
Assessed from 
national patient 
register 
 
Death of spouse or child: adjusted 
   Asthma hospitalisation: RR 1.43 (1.06-1.92) 
   Asthma hospitalisation + other related  
   outcomes: RR 1.40 (1.14-1.72) 
Death of spouse only: adjusted 
   Asthma hospitalisation: RR 1.59 (1.10-2.30) 
   Asthma hospitalisation + other related  
   outcomes: RR 1.64 (1.29-2.10) 
Strong 
Larsen et al 2014; Denmark; 
Prospective cohort study 
100,418 32,271 Up to 7 
years 
Psychosocial job 
strain/stress. Assessed 
using questionnaire and 
telephone interviews. 
Assessed for events 
Maternal reported 
current asthma 
and atopic 
dermatitis (AD). 
Assessed using 
Work stress and asthma + AD: adjusted 
  High vs low strain: OR 1.11 (0.88-1.40) 
  Active vs low strain: OR 1-09 (0.95-1.25) 
  Passive vs low strain: OR 1.10 (0.91-1.34) 
 
Moderate 
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during 2
nd
 trimester ISAAC-based 
questionnaire 
Results also given in the paper for having asthma and 
no AD and for having AD and no asthma 
 
Lee et al 2016; USA; 
Prospective cohort study 
989 765 Up to 6 
years 
Maternal questionnaire-
reported NLEs in 11 
domains (eg, financial, 
legal, career, 
relationships, home 
safety, community safety, 
medical issues pertaining 
to self, medical issues 
pertaining to others, 
home issues, authority, 
and prejudice) any time 
during pregnancy. 
Maternal reported 
clinician-
diagnosed asthma 
NLEs and asthma onset: adjusted 
 
All 
  1-2 NLEs vs none: OR 1.05 (0.59-1.88) 
  3-4 NLEs vs none: OR 1.60 (0.88-2.92) 
  ≥5 NLEs vs none: OR 2.02 (1.05-3.87) 
  Continuous: OR 1.31 (1.07-1.60) 
Boys:  
  Continuous: OR 1.38 (1.06-1.79) 
Girls: 
  Continuous: OR 1.17 (0.84-1.63) 
Results also given in paper for mutual adjustment for 
prenatal and postnatal maternal stress 
 
 
Lefevre et al 2011; France; 
Case-control study 
Cases: 142 
Controls: 142 
Cases: 138 
Controls: 109 
<2 years Maternal questionnaire-
reported anxiety and 
depression symptoms 
occurring any time during 
pregnancy 
Maternal reported 
wheeze and 
objective 
measures of 
eosinophila and 
IgE sensitisation 
Depression and wheeze: adjusted 
  OR 1.55 (0.12-19.8) 
 
Anxiety and wheeze: adjusted 
  OR 1.98 (0.69-5.68) 
 
 
Moderate 
Lin et al 2004; Taiwan; 
Prospective cohort study 
353 334 At birth Maternal questionnaire- 
reported stress 
(comprising nervousness, 
exhaustion, anxiety, 
tiredness, working stress, 
and discouragement) at 
any time during 
pregnancy 
Cord blood IgE 
sensitisation  
Maternal stress and cord blood IgE sensitisation: 
adjusted 
   OR 7.7 (1.1- 58.9) 
 
Maternal nervousness and cord blood IgE 
sensitisation: adjusted 
  Occasionally vs never/seldom: OR 1.1 (0.5-2.5) 
  Regularly vs never/seldom: OR 4.0 (1.3-12.8) 
 
Moderate 
Liu et al 2015; Denmark; 
Retrospective cohort study 
755,358 733,685 Up to 3 
years 
Maternal depression and 
use of antidepressant 
drugs throughout 
pregnancy. Assessed 
from population register 
Asthma onset 
assessed from 
medication 
prescription 
database 
Maternal depression vs none: adjusted 
  HR 1.25 (1.20-1.30) 
 
Use of antidepressant vs non-use: adjusted 
  HR 1.25 (1.18-1.33) 
 
Strong 
Liu et al 2015; Denmark; 
Retrospective cohort study 
755,358 750,058 Up to 15 
years 
Maternal bereavement 
throughout pregnancy. 
Assessed from 
population register 
Asthma onset 
assessed from 
medication 
prescription 
database 
Maternal bereavement vs none: adjusted 
  0-3 years: HR 1.04 (1.00-1.07) 
  4-15 years: HR 1.02 (0.96-1.09) 
Timing of maternal bereavement: adjusted 
  0-3 years: 1
st
 trimester: HR 1.05 (0.95-1.15); 2
nd
  
  trimester: HR 0.99 (0.91-1.08); 3
rd
 trimester: HR 1.06  
Strong 
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  (0.96-1.17) 
  4-15 years: 1st trimester: HR 1.06 (0.89-1.27); 2nd  
  trimester: HR 0.88 (0.74-1.04); 3
rd
 trimester: HR 0.95  
  (0.77-1.16) 
Results also given in the paper for type of relative 
death and cause of death and also stratified by 
maternal asthma history 
 
Peters et al 2012; USA; 
Prospective cohort study 
500 403 At birth Maternal questionnaire- 
reported NLEs (financial, 
legal, career, 
relationships, medical, 
safety in community and 
home, difficulty with 
authority, and 
discrimination) during 3
rd
 
trimester 
 
Total cord blood 
IgE sensitisation 
using CAP 
fluorescent 
enzyme 
immunoassay 
NLEs score and log cord blood IgE in all women: 
   β 0.10 (0.03-0.16) 
 
NLEs score and log cord blood IgE in atopic women:  
β 0.13 (0.02-0.24) 
 
NLEs score and log cord blood IgE in all women: 
   β 0.05 (-0.03-0.14) 
Moderate 
Polloni et al 2015; Italy; 
Case-control study 
Cases: 67 
 
Controls: not 
indicated 
Cases: 59 
Controls: 59 
Mean 8.3 
years 
Maternal questionnaire- 
reported NLEs: 
bereavement, divorce or 
separation, financial 
problem, and anxiety 
symptoms at any time 
during pregnancy 
 
Food allergy 
assessed via IgE, 
skin prick test, 
clinical evaluation 
Only descriptive results are given in paper Weak 
Radhakrishnan et al 2016; 
Canada; Retrospective 
cohort study 
 
122,333 122,333 12 years Maternal use of mental 
health services any time 
during the 12 months 
preceding child birth. 
Assessed from health 
administrative records 
 
Physician 
diagnosed asthma 
based on health 
administrative 
records 
Maternal stress and asthma: adjusted 
OR 1.16 (1.12-1.20) 
Moderate 
Reyes et al 2011; USA; 
Prospective cohort study 
727 279 Up to 5 
years 
Maternal questionnaire-
reported demoralisation 
during the 3
rd
 trimester 
Maternal 
questionnaire-
reported wheeze. 
Serum total and 
specific IgE 
sensitisation to 
inhalant allergens 
Unit increase in maternal demoralisation score: 
adjusted 
   Any wheeze at 5 yrs: OR 1,66 (1.29-2.14) 
   Transient wheeze (3-30 mo): OR 2.25 (1.34-3.76) 
   Late onset wheeze (>30 mo): OR 1.39 (0.61-3.17) 
   Persistent wheeze (3-5 yrs): OR 2.69 (1.52-4.76) 
   Specific IgE sensitisation: OR 0.96 (0.57-1.60) 
 
Moderate 
Rosa et al 2016; Mexico; 
Prospective cohort study 
815 417 
Boys: 211 
Girls: 206 
 
Up to 4 
years 
Maternal questionnaire-
reported NLEs in 11 
domains (financial, legal, 
career, relationship, 
Maternal reported 
ever and current 
wheeze using the 
ISAAC 
Unit increase in NLEs scores and ever wheeze: 
adjusted 
  All: RR 1.08 (1.00-1.16) 
  Boys: RR 1.12 (1.02-1.24) 
Moderate 
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home safety, 
neighbourhood safety, 
medical issues (self and 
others), home, prejudice, 
and authority) during the 
2
nd
 or 3
rd
 trimester 
 
questionnaire   Girls: RR 1.03 (0.92-1.15) 
 
Unit increase in NLEs scores and current wheeze: 
adjusted 
  All: RR 1.12 (1.00-1.26) 
  Boys: RR 1.11 (0.96-1.28) 
  Girls: RR 1.11 (0.93-1.34) 
 
Sausenthaler et al 2009; 
Germany; Prospective cohort 
study 
3097 3004 Up to 6 
years 
Indicators of 
psychological, social, and 
serological stress at any 
time during pregnancy. 
Assessed from maternity 
cards 
Maternal 
questionnaire-
reported atopic 
eczema 
Any stress and atopic eczema: adjusted 
  Atopic eczema by 1 year: OR 1.24 (0.72-2.13) 
  Atopic eczema by 2 years: OR 1.48 (0.95-2.30) 
  Atopic eczema by 3 years: OR 1.06 (0.66-1.70) 
  Atopic eczema by 4 years: OR 1.06 (0.67-1.68) 
  Atopic eczema by 5 year: OR 1.21 (0.76-1.91) 
  Atopic eczema by 6 year: OR 1.13 (0.71-1.79) 
 
Moderate 
Sternthal et al 2009; USA; 
Prospective cohort study 
500 478 At birth Maternal questionnaire-
reported exposure to 
interpersonal trauma 
during the 3
rd
 trimester 
Total cord blood 
IgE sensitisation 
using CAP 
fluorescent 
enzyme 
immunoassay 
Interpersonal trauma vs none: adjusted 
OR 2.19 (0.89-5.38) 
Moderate 
Turcotte-Tremblay et al 
2014; Canada; Prospective 
cohort study 
224 68 11-12 years Maternal questionnaire-
reported posttraumatic 
stress disorder occurring 
at any time during 
pregnancy 
 
Maternal 
questionnaire-
reported doctor-
diagnosed current 
asthma, use of 
asthma 
medication and 
wheeze 
Maternal stress and wheeze: adjusted 
  Girls only: OR 1.11 (1.01-1.23) 
  Girls and boys: OR 0.97 (0.91-1.03) 
Maternal stress and asthma: adjusted 
  Girls only: OR 1.09 (1.00-1.19) 
  Boys only: OR 0.88 (0.78-0.99) 
  Girls and boys: OR 0.88 (0.78-0.99) 
Maternal stress and asthma medication: adjusted 
  Girls only: OR 1.12 (1.01-1.25) 
  Girls and boys: OR 0.95 (0.87-1.02) 
 
Moderate 
Wang et al 2013; Taiwan; 
Prospective cohort study 
24,200 19,381 Up to 3 
years 
Maternal questionnaire-
reported work stress 
occurring at any time 
during pregnancy 
Maternal 
questionnaire-
reported parent-
perceived and 
doctor-diagnosed 
AD 
Work stress and parent-perceived AD: adjusted 
  Intermediate vs low/no stress: OR 1.20 (1.00-1.46) 
  High vs low/no stress: OR 1.43 (1.20-1.70) 
Work stress and doctor-diagnosed AD: adjusted 
  Intermediate vs low/no stress: OR 1.22 (1.05-1.41) 
  High vs low/no stress: OR 1.34 (1.16-1.54) 
 
Moderate 
Wen et al 2011; Taiwan; 
Prospective cohort study 
1,264 730 Up to 2 
years 
Maternal questionnaire-
reported indicators of 
stress (vitality, vigour, 
happiness, anxiety, 
discouragement, 
Maternal reported 
AD via telephone 
Maternal stress and AD: adjusted 
  Medium vs low/no stress: OR 1.10 (0.40-2.80) 
  High vs low/no stress: OR 2.30 (1.10-5.30) 
Moderate 
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nervousness, tiredness, 
exhaustion, and work 
stress) occurring during 
the 3
rd
 trimester 
 
Wood et al 2011; USA; 
Prospective cohort study 
1,850 515 1 year Maternal questionnaire-
reported exposure to 
work stress, community 
violence, anxiety, and 
depression during the 2
nd
 
and 3
rd
 trimester 
 
Maternal 
questionnaire-
reported wheeze 
and atopic 
eczema. IgE 
sensitisation 
All estimates presented in figures. Higher maternal 
stress scores appeared associated with increased risk 
of wheeze and atopic eczema 
Moderate 
Wright et al 2010; USA; 
Prospective cohort study 
1,853 560 At birth Maternal questionnaire-
reported difficult life 
circumstances, economic 
strain, neighbourhood 
/block conditions, 
perceived community 
violence and housing 
worries. 
Cord blood 
cytokine 
responses 
Only p-values presented in paper, hence results 
difficult to interpret 
Moderate 
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Table S2: Domain specific quality assessment of studies on the association between maternal psychosocial stress during pregnancy 
and risk of allergy and asthma in the offspring 
 
Reference; country Overall risk of 
bias assessment 
Risk of bias assessment for study components 
Study design Exposure 
assessment 
Outcome 
assessment 
Selection bias Confounding 
Andersson et al 2016; USA 
 
Moderate Strong Moderate Strong Moderate Moderate 
Bandoli et al 2016; USA 
 
Moderate Moderate Moderate Moderate Weak moderate 
Bidaki et al 2011; Iran 
 
Moderate Strong Moderate Strong Moderate Weak 
Braig et al 2016; Germany 
 
Strong Strong Strong Strong Moderate Moderate 
Chang et al 2016; South Korea 
 
Moderate Strong Moderate Moderate Moderate Moderate  
Cheng et al 2015; Singapore 
 
Moderate Strong Moderate Moderate Moderate Moderate 
Chiu et al 2012; Chiu et al 2014; USA 
 
Moderate Strong Moderate Moderate Moderate Moderate 
Cookson et al 2009; UK 
 
Moderate Strong Moderate Moderate Moderate Moderate 
de Marco et al 2012; Italy 
 
Moderate Weak Moderate Moderate Moderate Moderate 
Fang et al 2011; Sweden 
 
Strong Strong Strong Strong Moderate Moderate 
Guxens et al 2014; Netherlands 
 
Moderate Strong Moderate Moderate Moderate Moderate 
Hartwig et al 2014; Australia 
 
Moderate Strong Moderate Moderate Weak Moderate 
Khashan et al 2012; Sweden Strong Strong Strong Strong Moderate Moderate 
Larsen et al 2014; Denmark Moderate Strong Moderate Moderate Moderate Moderate 
Lee et al 2016; USA Moderate Strong Moderate Moderate Moderate Moderate 
Lefevre et al 2011; France Moderate Moderate Moderate Moderate Weak Moderate 
Lin et al 2004; Taiwan Moderate Strong Moderate Strong Moderate Moderate 
Liu et al 2015; Liu et al in press; 
Denmark 
Strong Strong Strong Strong Moderate Moderate 
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Peters et al 2012; USA Moderate Strong Moderate Strong Moderate Moderate 
Polloni et al 2015; Italy Weak Moderate Moderate Moderate Weak Weak 
Radhakrishnan et al; Canada Moderate Strong Moderate Moderate Moderate Moderate  
Reyes et al 2011; USA Moderate Strong Moderate Moderate Weak Moderate 
Rosa et al 2016; Mexico Moderate Strong Moderate Moderate Moderate Moderate 
Sausenthaler et al 2009; Germany Moderate Strong Strong Moderate Moderate Moderate 
Sternthal et al 2009; USA Moderate Strong Moderate Strong Moderate Moderate 
Turcotte-Tremblay et al 2014; 
Canada 
Moderate Strong Moderate Moderate Weak Moderate 
Wang et al 2013; Taiwan Moderate Strong Moderate Moderate Moderate Moderate 
Wen et al 2011; Taiwan Moderate Strong Moderate Moderate Moderate Moderate 
Wood et al 2011; USA; Moderate Strong Moderate Moderate Moderate Moderate 
Wright et al 2010; USA Moderate Strong Moderate Strong Moderate Moderate 
The overall risk assessment was based on the component risk assessments (i.e., on the suitability of the study design for the research question, validity of exposure and 
outcome assessments, potential for selection bias, adjustment for confounding factors). 
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Figure S1 Causal diagram describing the association between maternal prenatal stress and risk of 
allergy and asthma in the offspring 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maternal 
prenatal 
stress 
Offspring  
allergy/asthma 
Potential confounding factors 
Maternal asthma/allergy, smoking, 
socio-economic status, maternal body 
mass index, maternal occupation, 
maternal acid reflux disease, maternal 
use of antibiotics, pregnancy 
complications, parity 
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Figure S2. Association between maternal prenatal stress and risk of allergic rhinitis in 
the offspring, by timing of exposure during pregnancy: No major differences when 
Hartwig 2014’s 6-year-olds and 14-year-olds were analysed separately, hence we 
presented the results for 14-year-olds 
13 
 
 
 
 
Figure S3. Funnel plot investigating the presence of publication bias or small study effect 
in studies on the association between maternal prenatal stress and risk of allergy and 
asthma in the offspring 
 
 
